Tseng Ping-Tao, Chen Mu-Hong, Liang Chih-Sung
Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Department of Psychiatry, Taipei Veterans General Hospital, Taipei 112, Taiwan.
World J Psychiatry. 2022 Aug 19;12(8):1102-1104. doi: 10.5498/wjp.v12.i8.1102.
We read the impressive review article "Clozapine resistant schizophrenia: Newer avenues of management" with great enthusiasm and appreciation. The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia (CRS), and optimizing clozapine treatment is a key component. Disentangling the differences between treatment-resistant schizophrenia and CRS is important for studies addressing treatment strategies for these difficult-to-treat populations.